Barinthus Biotherapeutics plc. - BRNS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | — | U | D | 8,797,770.0 | 0.111 | 976,552.47 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,394.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 48,256.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 23,000.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 3,000.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,394.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 10,506.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | Chief Medical Officer | D | D | 140,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Medical Officer | D | D | 195,166.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Medical Officer | D | D | 361,530.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | Chief Medical Officer | A | A | 361,530.0 | — | — | 361,530.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 3,000.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 600,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 443,981.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 440,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 359,605.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 176,130.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 514,923.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | Chief Executive Officer | D | D | 728,454.0 | — | — | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 20,174.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,516.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 19,197.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 18,604.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 34,328.0 | 0.0 | 0.0 | 0.0 | View | |
| Sep 09, 2026 | — | D | D | 1,700.0 | — | — | 0.0 | View |